Exacerbation of Neonatal Hemolysis and Impaired Renal Iron Handling in Heme Oxygenase 1-Deficient Mice

Int J Mol Sci. 2020 Oct 20;21(20):7754. doi: 10.3390/ijms21207754.

Abstract

In most mammals, neonatal intravascular hemolysis is a benign and moderate disorder that usually does not lead to anemia. During the neonatal period, kidneys play a key role in detoxification and recirculation of iron species released from red blood cells (RBC) and filtered out by glomeruli to the primary urine. Activity of heme oxygenase 1 (HO1), a heme-degrading enzyme localized in epithelial cells of proximal tubules, seems to be of critical importance for both processes. We show that, in HO1 knockout mouse newborns, hemolysis was prolonged despite a transient state and exacerbated, which led to temporal deterioration of RBC status. In neonates lacking HO1, functioning of renal molecular machinery responsible for iron reabsorption from the primary urine (megalin/cubilin complex) and its transfer to the blood (ferroportin) was either shifted in time or impaired, respectively. Those abnormalities resulted in iron loss from the body (excreted in urine) and in iron retention in the renal epithelium. We postulate that, as a consequence of these abnormalities, a tight systemic iron balance of HO1 knockout neonates may be temporarily affected.

Keywords: Hmox1 gene; heme; heme oxygenase 1; iron; neonatal hemolysis; renal iron handling.

MeSH terms

  • Anemia / blood
  • Anemia / therapy
  • Animals
  • Animals, Newborn
  • Erythrocyte Count
  • Female
  • Heme / metabolism
  • Heme Oxygenase-1 / deficiency*
  • Heme Oxygenase-1 / genetics
  • Hemolysis*
  • Iron / metabolism*
  • Iron / urine
  • Kidney / metabolism*
  • Kidney / pathology
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Renal Insufficiency / genetics
  • Renal Insufficiency / metabolism*
  • Renal Insufficiency / therapy

Substances

  • Heme
  • Iron
  • Heme Oxygenase-1